TWD 72.7
(-0.41%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 1.37 Billion TWD | 1.22% |
2022 | 1.42 Billion TWD | 28.18% |
2021 | 1.11 Billion TWD | -8.14% |
2020 | 1.21 Billion TWD | -1.45% |
2019 | 1.22 Billion TWD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | 360.45 Million TWD | -21.96% |
2024 Q1 | 362.49 Million TWD | 53.55% |
2023 FY | 1.44 Billion TWD | 1.22% |
2023 Q3 | 515.53 Million TWD | 28.45% |
2023 Q4 | 236.07 Million TWD | -54.21% |
2023 Q1 | 291.39 Million TWD | -7.39% |
2023 Q2 | 401.34 Million TWD | 37.73% |
2022 Q4 | 314.65 Million TWD | 0.0% |
2022 FY | 1.42 Billion TWD | 28.18% |
2021 FY | 1.11 Billion TWD | -8.14% |
2020 FY | 1.21 Billion TWD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Allied Biotech Corporation | 88.71 Million TWD | -1447.031% |
GeneFerm Biotechnology Co., Ltd. | 153.56 Million TWD | -793.715% |
Easywell Biomedicals, Inc. | -162.73 Million TWD | 943.339% |
Synmosa Biopharma Corporation | 614.74 Million TWD | -123.253% |
Orient EuroPharma Co., Ltd. | 84.55 Million TWD | -1523.144% |
Center Laboratories, Inc. | -79.26 Million TWD | 1831.449% |
Tien Liang BioTech Co., Ltd. | 20.43 Million TWD | -6615.761% |
Orient Pharma Co., Ltd. | 27.75 Million TWD | -4845.17% |
InnoPharmax Inc. | -64.83 Million TWD | 2216.678% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 105.57 Million TWD | -1200.009% |
Excelsior Biopharma Inc. | -81.12 Million TWD | 1791.688% |
DV Biomed Co., Ltd. | 173.54 Million TWD | -690.804% |
Foresee Pharmaceuticals Co., Ltd. | -1 Billion TWD | 236.205% |
Handa Pharmaceuticals, Inc. | 695.79 Million TWD | -97.247% |
UniPharma Co., Ltd. | -27.3 Million TWD | 5126.307% |
Anxo Pharmaceutical Co., Ltd. | 53.15 Million TWD | -2482.042% |
Alar Pharmaceuticals Inc. | 385.52 Million TWD | -255.989% |
Winston Medical Supply Co., Ltd. | 196.1 Million TWD | -599.86% |
Mercury Biopharmaceutical Corporation | -45.69 Million TWD | 3103.793% |
Bioray Biotech Co., Ltd | -19.33 Million TWD | 7199.648% |
TSH Biopharm Corporation Limited | 63.63 Million TWD | -2056.896% |